↓ Skip to main content

Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome

Overview of attention for article published in Frontiers in Pharmacology, May 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome
Published in
Frontiers in Pharmacology, May 2023
DOI 10.3389/fphar.2023.1167260
Pubmed ID
Authors

Shuangcui Wang, Yuli Wang, Yun Deng, Jiaqi Zhang, Xijuan Jiang, Jianchun Yu, Jiali Gan, Wenyun Zeng, Maojuan Guo

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 14%
Student > Postgraduate 1 14%
Unknown 5 71%
Readers by discipline Count As %
Medicine and Dentistry 3 43%
Unknown 4 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2023.
All research outputs
#19,125,393
of 23,700,294 outputs
Outputs from Frontiers in Pharmacology
#8,832
of 17,323 outputs
Outputs of similar age
#143,384
of 209,139 outputs
Outputs of similar age from Frontiers in Pharmacology
#149
of 448 outputs
Altmetric has tracked 23,700,294 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,323 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,139 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 448 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.